<?xml version="1.0" encoding="UTF-8"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title><![CDATA[The Globe and Mail]]></title><link>https://www.theglobeandmail.com</link><atom:link href="https://www.theglobeandmail.com/arc/outboundfeeds/rss/author/640872/" rel="self" type="application/rss+xml"/><description><![CDATA[The Globe and Mail News Feed]]></description><lastBuildDate>Thu, 11 Jun 2026 18:09:37 +0000</lastBuildDate><language>en-ca</language><copyright>Copyright 2024 The Globe and Mail Inc. All rights reserved.</copyright><ttl>1</ttl><sy:updatePeriod>hourly</sy:updatePeriod><sy:updateFrequency>1</sy:updateFrequency><image><url>https://www.theglobeandmail.com/legacy/static/mobile.flag.rss.png</url><title>The Globe and Mail</title><link>https://www.theglobeandmail.com</link></image><item><title><![CDATA[Apotex raising IPO size to $1.3-billion on strong investor demand, source says ]]></title><link>https://www.theglobeandmail.com/business/article-apotex-ipo-tsx/</link><guid isPermaLink="true">https://www.theglobeandmail.com/business/article-apotex-ipo-tsx/</guid><dc:creator><![CDATA[Tim Kiladze]]></dc:creator><description><![CDATA[Canada’s largest drug manufacturer, which initially set out to raise $1-billion, will price its shares at $24 each ]]></description><pubDate>Tue, 09 Jun 2026 16:47:07 +0000</pubDate><content:encoded><![CDATA[<img src="https://www.theglobeandmail.com/resizer/v2/DOYXG5SMPNFI7JLHGOPQDMVB6M.JPG?auth=03218ce73efe4ea28395ed375d874420d995e3fb4d7ca6d86a7ecf01be6de5f1&smart=true&width=5000&height=3333" alt="Workers leave an Apotex pharmaceutical manufacturing facility in Richmond Hill, Ont., on Tuesday." height="3333" width="5000"/>]]></content:encoded><media:content url="https://www.theglobeandmail.com/resizer/v2/DOYXG5SMPNFI7JLHGOPQDMVB6M.JPG?auth=03218ce73efe4ea28395ed375d874420d995e3fb4d7ca6d86a7ecf01be6de5f1&amp;smart=true&amp;width=5000&amp;height=3333" type="image/jpeg" height="3333" width="5000"><media:description type="plain"><![CDATA[Workers leave an Apotex pharmaceutical manufacturing facility in Richmond Hill, Ont., on June 9, 2026. (Sammy Kogan/The Globe and Mail)]]></media:description><media:credit role="author" scheme="urn:ebu">Sammy Kogan</media:credit></media:content></item><item><title><![CDATA[Apotex shares jump 12% in TSX debut of billion-dollar IPO]]></title><link>https://www.theglobeandmail.com/business/article-apotex-shares-jump-12-in-tsx-debut-of-billion-dollar-ipo/</link><guid isPermaLink="true">https://www.theglobeandmail.com/business/article-apotex-shares-jump-12-in-tsx-debut-of-billion-dollar-ipo/</guid><dc:creator><![CDATA[Tim Kiladze]]></dc:creator><description><![CDATA[Drug manufacturer’s strong showing a sign of solid investor support]]></description><pubDate>Wed, 10 Jun 2026 16:24:07 +0000</pubDate><content:encoded><![CDATA[<p>Shares of Apotex Health Corp. rose during their first morning of trading, a sign of solid investor support for the drug manufacturer’s billion-dollar initial public offering.</p>]]></content:encoded><media:content url="https://www.theglobeandmail.com/resizer/v2/N2LMCQAWVZBYDDHMOEZJEGVY6E.JPG?auth=7cb9d563cd5e59bd88c961450ecdb56f0796ca2055bd736ad0617cab743d7ace&amp;smart=true&amp;width=3600&amp;height=2400" type="image/jpeg" height="2400" width="3600"><media:description type="plain"><![CDATA[FILE PHOTO: A general view shows Apotex pharmaceutical company as Humber River Hospital's mobile vaccine clinic vaccinate employees as part of the coronavirus disease (COVID-19) vaccination campaign, in Toronto, Ontario, Canada April 13, 2021. REUTERS/Carlos Osorio/File Photo]]></media:description><media:credit role="author" scheme="urn:ebu">Carlos Osorio</media:credit></media:content></item><item><title><![CDATA[The51, a VC firm focused on female-led companies, launches third fund with BMO as lead investor]]></title><link>https://www.theglobeandmail.com/business/article-the51-vc-firm-women-founders-third-fund-bmo-lead-investor/</link><guid isPermaLink="true">https://www.theglobeandmail.com/business/article-the51-vc-firm-women-founders-third-fund-bmo-lead-investor/</guid><dc:creator><![CDATA[Tim Kiladze]]></dc:creator><description><![CDATA[Calgary firm aims to raise $30-million for fund that will funnel capital to businesses founded by women  ]]></description><pubDate>Mon, 01 Jun 2026 09:00:00 +0000</pubDate><content:encoded><![CDATA[<img src="https://www.theglobeandmail.com/resizer/v2/UMPWS2TECVPSZOCOGUZ4OUXZXA.jpg?auth=7401852e7e1f00e2f638db7f9e9be0ebc271cc9f01dd51f51e5229e994896581&smart=true&width=4000&height=3071" alt="The51's co-founders, Judy Fairburn and Shelley Kuipers, in Calgary in 2021." height="3071" width="4000"/>]]></content:encoded><media:content url="https://www.theglobeandmail.com/resizer/v2/UMPWS2TECVPSZOCOGUZ4OUXZXA.jpg?auth=7401852e7e1f00e2f638db7f9e9be0ebc271cc9f01dd51f51e5229e994896581&amp;smart=true&amp;width=4000&amp;height=3071" type="image/jpeg" height="3071" width="4000"><media:description type="plain"><![CDATA[Venture capital firm "The51" founders Judy Fairburn, left, co-CEO and fund managing partner, and Shelley Kuipers, co-CEO, general partner and growth officer, are shown in Calgary, Alta., Wednesday, Oct. 6, 2021.THE CANADIAN PRESS/Jeff McIntosh]]></media:description><media:credit role="author" scheme="urn:ebu">Jeff McIntosh</media:credit></media:content></item><item><title><![CDATA[RBC’s insurance head to depart two years into group executive role]]></title><link>https://www.theglobeandmail.com/business/article-royal-bank-of-canada-insurance-head-jennifer-publicover-depart/</link><guid isPermaLink="true">https://www.theglobeandmail.com/business/article-royal-bank-of-canada-insurance-head-jennifer-publicover-depart/</guid><dc:creator><![CDATA[Tim Kiladze]]></dc:creator><description><![CDATA[Jennifer Publicover to leave the bank June 1 and Neil McLaughlin will oversee the division]]></description><pubDate>Wed, 27 May 2026 22:54:54 +0000</pubDate><content:encoded><![CDATA[<img src="https://www.theglobeandmail.com/resizer/v2/QR5PCRUWQJEBDG6VGJ6XYE7SYY.JPG?auth=79389aa218dec61039affe8b1bc38894569ea5457834be6351bceec79c530711&smart=true&width=5052&height=3573" alt="RBC is set to report second-quarter earnings on Thursday." height="3573" width="5052"/>]]></content:encoded><media:content url="https://www.theglobeandmail.com/resizer/v2/QR5PCRUWQJEBDG6VGJ6XYE7SYY.JPG?auth=79389aa218dec61039affe8b1bc38894569ea5457834be6351bceec79c530711&amp;smart=true&amp;width=5052&amp;height=3573" type="image/jpeg" height="3573" width="5052"><media:description type="plain"><![CDATA[Pedestrians walk by the Royal Bank of Canada on Spring Garden Rd in Halifax on October. 14, 2025. ]]></media:description><media:credit role="author" scheme="urn:ebu">Maria Collins</media:credit></media:content></item></channel></rss>